<Anchor>
Following the AstraZeneca vaccine, the corona vaccine made by Janssen also had a side effect of causing blood clots.
US health officials have recommended discontinuing use.
The European launch has also been postponed.
Correspondent Yunsoo Kim reports from Washington.
<Reporter> The
US Centers for Disease Control and Prevention and the Food and Drug Administration issued a joint statement and recommended that Janssen's vaccine be discontinued.
A rare but severe form of thrombosis has been reported as a side effect.
[Acting Woodcock/U.S. FDA Director: These side effects are very rare, but the safety of the vaccine and the safety of the Americans are top priorities.] In the
United States so far, about 6.8 million people have received the Janssen vaccine.
Of these, six had thrombosis with platelet reduction.
Similar to the side effects of the AstraZeneca vaccine, one of them died and the other was known to be critical.
Inoculations with thrombosis were women between the ages of 18 and 48, and symptoms were found between 6 and 13 days after vaccination.
U.S. health officials explained that if you get the Janssen vaccine within two weeks, you should look for breathing problems or headaches, but if it's been more than a month, you're unlikely to have side effects.
[Pouch/U.S. National Institute for Allergy and Infectious Diseases: If you are worried about the impact of those who received the vaccine a month or two ago, you can say that you don't have to worry at all.]
After the ban on use, 35 states in the United States immediately stopped vaccinating, and South Africa stopped vaccinating.
Johnson & Johnson said it was delaying the launch of the Janssen vaccine in Europe, raising concerns that it will disrupt global vaccine distribution in the future.